Cargando…
CKAP2L Promotes Esophageal Squamous Cell Carcinoma Progression and Drug-Resistance by Modulating Cell Cycle
Esophageal squamous cell carcinoma (ESCC) is one of the most common types of cancer and the leading cause of cancer-related mortality worldwide, especially in Asia. In this study, the gene CKAP2L was selected by GEO, TCGA, and GTEx database analysis. The high expression of CKAP2L is related to the o...
Autores principales: | Chen, Wenhu, Wang, Yu, Wang, Lifang, Zhao, Hongguang, Li, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462994/ https://www.ncbi.nlm.nih.gov/pubmed/36090903 http://dx.doi.org/10.1155/2022/2378253 |
Ejemplares similares
-
LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma
por: Chen, Wenhu, et al.
Publicado: (2021) -
The RBP1–CKAP4 axis activates oncogenic autophagy and promotes cancer progression in oral squamous cell carcinoma
por: Gao, Ling, et al.
Publicado: (2020) -
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
por: Li, Qi, et al.
Publicado: (2022) -
Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
por: Liu, Zhi, et al.
Publicado: (2023) -
ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma
por: Cui, Yuanbo, et al.
Publicado: (2022)